Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

Clinical Trial ID NCT01632332

PubWeight™ 3.83^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01632332

Top papers